Table 1.
Characteristics of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–positive, complicated, and noncomplicated coronavirus disease (COVID-19) patient cohorts.
| Characteristic | SARS-CoV-2 positive (n=4353) | Complicated COVID-19 (n=173) | Noncomplicated COVID-19 (n=4180) | |||||
| Demographic information | ||||||||
|
|
Age (years), median (IQR) | 35 (22-54) | 70 (58-80) | 34 (22-52) | ||||
|
|
|
<18, n (%) | 647 (15) | 0 (0) | 647 (15.6) | |||
|
|
|
18-50, n (%) | 2354 (54.5) | 21 (12.1) | 2333 (56.3) | |||
|
|
|
50-60, n (%) | 609 (14.1) | 29 (16.8) | 580 (14) | |||
|
|
|
60-70, n (%) | 376 (8.7) | 35 (20.2) | 341 (8.2) | |||
|
|
|
70-80, n (%) | 232 (5.4) | 42 (24.3) | 190 (4.6) | |||
|
|
|
≤80, n (%) | 135 (3.1) | 46 (26.6) | 89 (2.1) | |||
|
|
Female, n (%) | 1939 (44.5) | 50 (28.9) | 1889 (45.2) | ||||
|
|
Follow-up days, median (IQR) | 30 (24-36) | 28 (21-33) | 30 (24-36) | ||||
| Comorbidities, n (%) | ||||||||
|
|
Chronic respiratory diseases | 481 (11) | 39 (22.5) | 442 (10.6) | ||||
|
|
|
Chronic obstructive pulmonary disease | 310 (7.1) | 24 (13.9) | 286 (6.8) | |||
|
|
|
Other chronic pulmonary disease | 153 (3.5) | 10 (5.8) | 143 (3.4) | |||
|
|
|
Pleural effusion | 41 (0.9) | 4 (2.3) | 37 (0.9) | |||
|
|
Cardiovascular diseases | 310 (7.1) | 57 (32.9) | 253 (6.1) | ||||
|
|
|
Ischemic heart disease | 132 (3) | 27 (15.6) | 105 (2.5) | |||
|
|
|
Congestive heart failure | 30 (0.7) | 11 (6.4) | 19 (0.5) | |||
|
|
|
Cerebrovascular disease | 57 (1.3) | 15 (8.7) | 42 (1) | |||
|
|
|
Peripheral vascular disease | 23 (0.5) | 7 (4) | 16 (0.4) | |||
|
|
|
Other cardiovascular diseases | 199 (4.6) | 41 (23.7) | 158 (3.8) | |||
|
|
Hypertension | 627 (14.4) | 102 (59) | 525 (12.6) | ||||
|
|
Immunosuppression | 164 (3.8) | 31 (17.9) | 133 (3.2) | ||||
|
|
Cancer | 205 (4.7) | 33 (19.1) | 172 (4.1) | ||||
|
|
Deficiency anemia | 423 (9.7) | 18 (10.4) | 405 (9.7) | ||||
|
|
Liver and kidney diseases | |||||||
|
|
|
Liver disease | 404 (9.3) | 28 (16.2) | 376 (9) | |||
|
|
|
Chronic kidney disease | 384 (8.8) | 86 (49.7) | 298 (7.1) | |||
|
|
|
End stage renal disease | 85 (2) | 26 (15) | 59 (1.4) | |||
|
|
Fluid and electrolyte disorders | 394 (9.1) | 37 (21.4) | 357 (8.5) | ||||
|
|
Metabolic diseases |
|
|
|
||||
|
|
|
Diabetes | 362 (8.3) | 58 (33.5) | 304 (7.3) | |||
|
|
|
Obesity (BMI≥30) | 874 (20.1) | 73 (42.2) | 801 (19.2) | |||
|
|
Neurological and cognitive disorders | |||||||
|
|
|
Neurological disorders | 294 (6.8) | 57 (32.9) | 237 (5.7) | |||
|
|
|
Paralysis | 53 (1.2) | 12 (6.9) | 41 (1) | |||
|
|
|
Depression | 578 (13.3) | 53 (30.6) | 525 (12.6) | |||
|
|
|
Cognitive impairment | 87 (2) | 28 (16.2) | 59 (1.4) | |||
|
|
Other | |||||||
|
|
|
Hospitalization | 931 (21.4) | 92 (53.2) | 839 (20.1) | |||
|
|
|
Smoking | 643 (14.8) | 41 (23.7) | 602 (14.4) | |||
|
|
|
|
Current smoker | 514 (11.8) | 30 (17.3) | 484 (11.6) | ||
|
|
|
|
Past smoker | 129 (3) | 11 (6.4) | 118 (2.8) | ||
|
|
|
Nursing home | 67 (1.5) | 23 (13.3) | 44 (1.1) | |||
|
|
|
Home care | 44 (1) | 17 (9.8) | 27 (0.6) | |||